SEBASTIANI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.695
EU - Europa 26.346
AS - Asia 15.636
SA - Sud America 2.154
Continente sconosciuto - Info sul continente non disponibili 683
AF - Africa 391
OC - Oceania 126
Totale 77.031
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.936
IT - Italia 15.065
SG - Singapore 4.611
GB - Regno Unito 4.240
CN - Cina 4.096
HK - Hong Kong 1.771
BR - Brasile 1.602
VN - Vietnam 1.491
SE - Svezia 1.334
DE - Germania 934
FR - Francia 916
BD - Bangladesh 867
FI - Finlandia 835
UA - Ucraina 659
RU - Federazione Russa 580
KR - Corea 538
NL - Olanda 537
TR - Turchia 524
IN - India 367
CA - Canada 356
JP - Giappone 299
ID - Indonesia 288
MX - Messico 252
BG - Bulgaria 248
IE - Irlanda 206
AR - Argentina 192
PL - Polonia 134
ZA - Sudafrica 130
AU - Australia 115
IQ - Iraq 113
PK - Pakistan 95
CH - Svizzera 89
ES - Italia 85
EC - Ecuador 84
AE - Emirati Arabi Uniti 77
MY - Malesia 73
CL - Cile 72
LT - Lituania 72
TN - Tunisia 66
CO - Colombia 65
BE - Belgio 63
RO - Romania 58
SA - Arabia Saudita 57
AT - Austria 56
EG - Egitto 48
VE - Venezuela 46
PH - Filippine 44
IR - Iran 41
MA - Marocco 38
TH - Thailandia 35
BZ - Belize 32
NP - Nepal 32
JO - Giordania 31
PT - Portogallo 31
UZ - Uzbekistan 31
PE - Perù 30
TW - Taiwan 27
KE - Kenya 26
DZ - Algeria 24
PY - Paraguay 24
CZ - Repubblica Ceca 22
DK - Danimarca 22
HU - Ungheria 22
EU - Europa 21
AZ - Azerbaigian 20
GR - Grecia 20
BO - Bolivia 19
JM - Giamaica 18
HN - Honduras 17
IL - Israele 16
UY - Uruguay 16
AL - Albania 15
LV - Lettonia 15
OM - Oman 15
LB - Libano 14
TT - Trinidad e Tobago 14
DO - Repubblica Dominicana 13
RS - Serbia 13
BY - Bielorussia 11
HR - Croazia 11
NO - Norvegia 11
NZ - Nuova Zelanda 11
CR - Costa Rica 10
PA - Panama 10
KG - Kirghizistan 9
LU - Lussemburgo 9
NI - Nicaragua 9
CY - Cipro 8
ET - Etiopia 8
KW - Kuwait 7
MD - Moldavia 7
PR - Porto Rico 7
QA - Qatar 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
GT - Guatemala 5
KZ - Kazakistan 5
BS - Bahamas 4
CI - Costa d'Avorio 4
KH - Cambogia 4
Totale 76.271
Salva come PNG Salva come JPEG
Città #
Singapore 3.141
Santa Clara 3.040
Southend 2.843
Ashburn 2.695
Fairfield 2.496
Hong Kong 1.723
Chandler 1.403
Woodbridge 1.392
Hefei 1.383
Milan 1.191
Houston 1.159
San Jose 1.138
Rome 1.050
Jacksonville 946
Seattle 893
Wilmington 893
Chicago 887
Los Angeles 787
Cambridge 784
Ann Arbor 783
London 735
Nyköping 687
Council Bluffs 676
Dearborn 669
Beijing 634
Helsinki 633
The Dalles 494
Seoul 476
Ho Chi Minh City 437
New York 408
Salt Lake City 400
Modena 379
Hanoi 377
Bologna 275
Naples 265
Florence 263
San Diego 263
Izmir 244
Dallas 242
Princeton 234
Sofia 234
Lauterbourg 211
Buffalo 210
Turin 210
Jakarta 198
Palermo 194
Redwood City 190
Moscow 186
Bari 184
Eugene 182
Tampa 174
Shanghai 163
Elk Grove Village 162
Tokyo 160
São Paulo 154
Dublin 153
Genoa 148
Des Moines 139
Frankfurt am Main 136
Catania 126
Verona 125
Bremen 112
Cagliari 104
Columbus 104
Boardman 102
Padova 99
Orem 93
Toronto 92
Falls Church 91
Sterling 87
Da Nang 84
Mexico City 79
Atlanta 77
Brescia 77
Munich 76
Guangzhou 73
Lancaster 72
Manchester 67
Parma 67
Phoenix 67
Brooklyn 66
Kent 63
Montreal 61
Detroit 58
Miami 58
Warsaw 57
Haiphong 56
Chennai 55
Redondo Beach 55
Denver 53
Monza 53
Dulles 49
Johannesburg 49
Bergamo 48
Perth 47
Perugia 47
Salerno 47
Amsterdam 46
Messina 45
Mumbai 45
Totale 45.738
Salva come PNG Salva come JPEG
Nome #
Prevalenza delle epatiti nelle malattie reumatiche 6.988
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.866
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.371
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.330
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 966
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 796
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 785
Semeiotica dell'articolazione temporo-mandibolare 563
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 486
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 463
B-cells and mixed cryoglobulinemia 444
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 443
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 417
Capillaroscopia del letto periungueale in pazienti affetti da artrite psoriasica e spondilite anchilosante. 413
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 408
Validation of the classification criteria for cryoglobulinaemic vasculitis 396
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 393
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 392
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 392
Thymus alterations and systemic sclerosis 385
Heart involvement and systemic sclerosis 381
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 374
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 371
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 365
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 361
Current treatment of hepatitis C-associated rheumatic diseases. 359
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 358
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 357
Cardiac Involvement in Systemic Vasculitis 354
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 350
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 349
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 348
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 346
Aortic pulse wave velocity measurement in systemic sclerosis patients. 343
Elevated Troponin Serum Levels in Adult Onset Still's Disease 342
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 341
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 341
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 340
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 331
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 327
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 327
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 327
Acute exacerbation of interstitial lung disease associated with rheumatic disease 326
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 325
L-Arginine in pregnant scleroderma patients 325
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 324
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 322
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 319
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 318
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 317
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 316
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 315
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 312
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 310
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 310
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 308
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 303
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 303
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry. 301
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 298
HCV and cryoglobulinemic vasculitis. 296
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 295
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 295
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 292
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 289
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 288
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 286
Cardiovascular risk and prostanoids in systemic sclerosis 285
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 285
Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection 284
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 284
HCV associated cryoglobulinemic vasculitis 281
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients 281
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 281
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 280
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 280
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 279
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases 278
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 278
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 277
EFFICACIA, SAFETY E TOLLERANZA DI ADALIMUMAB IN PRIMA E SECONDA LINEA IN PAZIENTI CON ARTRITE REUMATOIDE: ESPERIENZA DAI REGISTRI ITALIANI DEI FARMACI BIOLOGICI 277
Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent? 276
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 276
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection 276
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 275
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 274
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement 273
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 272
New targeted molecular therapies for dedifferentiated thyroid cancer 271
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 265
Systemic sclerosis following human cytomegalovirus infection 262
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 262
The Expanding Spectrum of Clinical Features in HCV-Related Mixed Cryoglobulinemia 261
HCV-related rheumatic manifestations and therapeutic strategies 260
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 259
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 259
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 259
Micro and Nanoparticles As Possible Causative-Prognostic Co-Factors Of Mixed Cryoglobulinemia Syndrome 258
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 258
Treatment of HCV-related mixed cryoglobulinemia 256
Totale 46.064
Salva come PNG Salva come JPEG
Categoria #
all - tutte 281.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 281.537
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.162 278 415 377 408 239 423 271 312 585 472 748 634
2022/20237.737 676 522 436 487 804 957 523 753 945 354 745 535
2023/20247.596 470 503 547 790 1.025 553 653 868 294 485 599 809
2024/202513.591 705 370 449 972 2.413 1.779 920 700 1.426 881 1.393 1.583
2025/202624.088 1.347 916 1.897 3.068 4.300 1.706 2.732 1.032 2.081 1.772 1.722 1.515
2026/2027830 830 0 0 0 0 0 0 0 0 0 0 0
Totale 77.031